Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Clinical trial NCT00006291 · COMPLETED
Trial details
- NCT number
- NCT00006291
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.